ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1864

H3K4me3 Peak Shape Dictates Transcription and Regulates Differential Expression in SLE

Kathleen E. Sullivan1, Lihua Shi2, Li Song3, Michelle Petri4 and Zhe Zhang5, 1Allergy Immunology, The Children's Hospital of Philadelphia, Philadelphia, PA, 2Immunology ARC 1216, The Children's Hospital of Philadelphia, Philadelphia, PA, 3Allergy Immunology, Children's Hospital of Philadelphia, Philadelphia, PA, 4Rheumatology, Johns Hopkins University Hospital, Baltimore, MD, 5Bioinformatics, Children's Hospital of Philadelphia, Bioinformatics, Philadelphia, PA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Epigenetics and transcriptional regulation, Lupus

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: H3K4me3 is a post-translational modification of histone H3 associated typically with gene activation.  We had previously characterized changes in H3K4me3 associated with SLE in monocytes and found that many genes had higher peaks of H3K4me3 in SLE.  In the current study, we further analyzed these changes to better define the transcription factors impacting these changes. 

Methods: Eight female controls and six female SLE monocyte samples were utilized for analysis.  The SLE patients had low to moderate disease activity and were not on high level immune suppression.  Using ChIP-seq data from these samples, we analyzed changes in breadth and shape of the H4K4me3 peaks in SLE and then correlated these changes with paired RNA-seq data.  H3K4me3 peaks were classified as Narrow, Extended Upstream, Extended Downstream and Extended Symmetric patterns.

Results: We found that there was a strong association between the H3K4me3 breadth and likelihood of differential expression. Genes with narrow H3K4me3 were less likely to have increased expression in SLE while those with extended H3K4me3 downstream of their TSSs were more likely to have increased expression in SLE. We then looked at the change of H3K4me3 breadth in SLE. H3K4me3 peak shape was mostly stable in primary monocytes. Among 907 sites that switched patterns from control to SLE, none of them switched between narrow sites and any of the three broad sites. The most common switch was 131 sites that switched from Extended Symmetric to Extended Downstream.  We previously reported that H3K4me3 increases in SLE were associated with increased expression of corresponding genes in SLE patients. To address the impact of location of H3K4me3, we analyzed changes in shape of H3K4me3 peaks in SLE with changes in transcript levels. Expression change was very sensitive to H3K4me3 change at the downstream regions. From 1% to 10%, every one percent increase of H3K4me3 at the immediate downstream region lead to a 1.5% increase in gene expression on average.  Of the genes having significantly increased expression in SLE, 78.8% also had increased H3K4me3 at the downstream regions, while the percentages were 55.0% and 47.1% for TSSs and upstream regions, respectively. Indeed, the average H3K4me3 change of these genes peaked (~8%) at approximately 700bp downstream of their TSSs.

Conclusion: This study provides refinement in our understanding of the epigenetic changes associated with SLE.  The change may occur adjacent to transcription factor binding where a histone modification enzyme has been recruited.  Efforts to identify such transcription factors have typically focused on upstream peaks, whereas our data supports a focus on the downstream peaks.  This finding may facilitate identification of epigenetic therapeutics.


Disclosure: K. E. Sullivan, Baxter, 2,Immune Deficiency Foundation, 5,Janssen Pharmaceutica Product, L.P., 5; L. Shi, None; L. Song, None; M. Petri, None; Z. Zhang, None.

To cite this abstract in AMA style:

Sullivan KE, Shi L, Song L, Petri M, Zhang Z. H3K4me3 Peak Shape Dictates Transcription and Regulates Differential Expression in SLE [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/h3k4me3-peak-shape-dictates-transcription-and-regulates-differential-expression-in-sle/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/h3k4me3-peak-shape-dictates-transcription-and-regulates-differential-expression-in-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology